Pharmacists have long been the cornerstone of community healthcare, trusted by patients for their accessibility and personalized care. Now, they are poised to play a transformative role in clinical trials, addressing the most pressing challenges in drug development.
Clinical trials often struggle to meet recruitment targets and timelines. On average, a clinical trial costs $700 million and takes 6–7 years to complete, with 80% of trials failing to finish on time. Moreover, diversity in patient recruitment and retention remains a significant hurdle.
Enter RxE2. By integrating community pharmacies into the clinical trial ecosystem, RxE2 is reimagining how trials are conducted. Through services like Direct Recruitment and Referral, Decentralized Trial Visits, and Clinical Trial Awareness campaigns, RxE2 connects trial sponsors with thousands of pharmacies, creating a streamlined, patient-centered approach.